China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical efficacy and mechanism of peripheral nerve balance surgery in the treatment of... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Autologous Platelet-Rich Plasma Submucosal Injection for Refractory Interstitial Cystit... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Nurses' empathy and cancer pain management: How compassion fatigue and psychological re... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Single-Arm Exploratory Study on the Efficacy of Crisugabalin Combined ... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Influence Mechanism of Psychological Capital on Compassion Fatigue Among... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Neuropsychiatric Symptom Trajectories and Cognitive Function Changes in Older Adults Wi... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of Generative Artificial Intelligence Combined with OSCE in the Teaching an... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study on MCT Diet for Preventing Obesity and Metabolic Problems in Patients wi... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation Between EEG-Guided Sleep Assessment and Resting-State Functional MRI in Pat... Read More
China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Perioperative Trastuzumab Rezetecan and Trastuzumab plus Sintilimab in the LocallyAdvan... Read More